The Global X Cannabis ETF (POTX) seeks to invest in companies across the cannabis industry. This includes companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, cannabidiol (i.e., CBD), or other related uses including but not limited to extracts, derivatives or synthetic versions.
The Global X Cannabis ETF (POTX) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index.
Globally, legal cannabis sales increased 48% from 2019 to 2020, exceeding $21bn. Forecasts suggest the market could surpass $55bn in 2026.1
Efforts to legalize cannabis are making progress in many countries, including the US. More than two-thirds of Americans live in a state where a form of legal cannabis is available.2
An evolving regulatory environment can make navigating the cannabis theme challenging. POTX delivers a basket of publicly-listed companies involved in multiple aspects of this emerging industry in a single trade.
1BDSA, Mar 2021
2Gallup, Nov 2020
| Ticker | POTX |
| Inception Date | 09/17/19 |
| CUSIP | 37954Y426 |
| ISIN | US37954Y4263 |
| Bloomberg Index Ticker | POTX |
| Primary Exchange | Nasdaq |
| Number of Holdings | 23 |
| Net Assets | $163,147,096 |
| Net Asset Value (NAV) | $11.44 |
| Shares Outstanding | 14,260,000 |
| Total Expense Ratio | 0.51% |
| 30-Day SEC Yield | N/A |
| Distribution Frequency | Semi-Annually |
|
As of recent month & quarter-end (06/30/21)
As of recent month & quarter-end (06/30/21)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | 37.94% | 38.12% | 33.57% |
| Since Inception | -24.51% | -25.35% | -29.02% |
| 1 Year | 37.94% | 38.12% | 33.57% |
| Since Inception | -24.51% | -25.35% | -29.02% |
| Year-to-Date | 40.13% | 40.17% | 39.41% |
| 1 Month | -9.75% | -9.13% | -9.94% |
| 3 Months | -13.27% | -13.54% | -13.65% |
| Since Inception | -39.47% | -40.68% | -45.79% |
| Year-to-Date | 40.13% | 40.17% | 39.41% |
| 1 Month | -9.75% | -9.13% | -9.94% |
| 3 Months | -13.27% | -13.54% | -13.65% |
| Since Inception | -39.47% | -40.68% | -45.79% |
Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.
| Return on Equity | -35.00% | |
| Weighted Avg. Market Cap | 1,619 M | |
| 2020 | 2021 | |
| Price-to-earnings | -1.13 | -7.76 |
| Price-to-book value | 2.33 | 3.26 |
Source: AltaVista Research, LLC
| Versus | Beta |
|---|---|
| S&P 500 | 1.53 |
| MSCI EAFE | 1.79 |
| MSCI Emg. Mkts | 1.17 |
| Standard Deviation | 71.60% |
Source: AltaVista Research, LLC
| % of Net Assets | ||
|---|---|---|
| Consumer Staples | 81.8 | |
| Health Care | 12.5 | |
| Financials | 4.2 | |
| Consumer Discretionary | 1.5 | |
Source: AltaVista Research, LLC
| % of Net Assets | ||
|---|---|---|
| Canada | 88.3 | |
| United States | 9.1 | |
| Australia | 2.5 | |
| Other/Cash | 0.1 | |
Source: AltaVista Research, LLC
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 10.55 | WEED CN | CANOPY GROWTH CORP | BYTN3W0 | 19.62 | 877,372 | 17,214,988.60 |
| 9.41 | SNDL | SUNDIAL GROWERS INC | BJV2RL7 | 0.80 | 19,270,083 | 15,358,256.15 |
| 8.90 | CRON CN | CRONOS GROUP INC | BF01YS3 | 7.12 | 2,040,420 | 14,522,908.37 |
| 8.08 | ACB | AURORA CANNABIS INC | BLB8BB7 | 7.08 | 1,860,826 | 13,174,648.08 |
| 7.56 | TLRY | TILRAY INC-CLASS 2 COMMON | BDD1B29 | 13.59 | 907,003 | 12,326,170.76 |
| 7.55 | HEXO CN | HEXO CORP | BMDCRL6 | 4.15 | 2,969,590 | 12,313,825.47 |
| 5.29 | OGI CN | ORGANIGRAM HOLDINGS INC | BQ963P6 | 2.45 | 3,528,121 | 8,632,174.35 |
| 4.57 | CWEB CN | CHARLOTTES WEB H | BGHY2B1 | 3.21 | 2,323,286 | 7,456,071.37 |
| 4.45 | RIV CN | RIV CAPITAL INC | BMFBP84 | 1.50 | 4,836,923 | 7,262,012.53 |
| 3.86 | VLNS CN | VALENS CO INC/THE | BKMPJ38 | 1.93 | 3,265,354 | 6,303,221.37 |
| 3.80 | ZYNE | ZYNERBA PHARMACE | BZ03R68 | 4.51 | 1,373,382 | 6,193,952.82 |
| 3.67 | CRBP | CORBUS PHARMACEU | BRYGB65 | 1.41 | 4,240,807 | 5,979,537.87 |
| 3.09 | XLY CN | AUXLY CANNABIS GROUP INC | BDGMQB3 | 0.21 | 24,404,627 | 5,040,475.85 |
| 2.90 | PCLO CN | PHARMACIELO LTD | BH4KPJ8 | 1.22 | 3,866,827 | 4,730,439.35 |
| 2.74 | TGOD CN | GREEN ORGANIC DU | BG0DCR1 | 0.25 | 17,893,790 | 4,477,534.14 |
| 2.04 | FAF CN | FIRE & FLOWER HO | BJJG8Y1 | 0.72 | 4,605,399 | 3,329,160.02 |
| 2.03 | AH CN | ALEAFIA HEALTH INC | BDRXWQ2 | 0.30 | 10,967,890 | 3,310,798.11 |
| 1.66 | LABS CN | MEDIPHARM LABS CORP | BG87WT7 | 0.33 | 8,109,803 | 2,705,737.19 |
| 1.61 | CPH AU | CRESO PHARMA LTD | BDGMXK1 | 0.10 | 27,489,235 | 2,629,987.38 |
| 1.59 | YCBD | CBDMD INC | BJHG360 | 2.60 | 1,000,306 | 2,600,795.60 |
| 1.55 | TBP CN | TETRA BIO-PHARMA INC | BDCBXM4 | 0.21 | 11,972,226 | 2,520,268.41 |
| 1.47 | CRDL CN | CARDIOL THERAP-A | BHZT969 | 2.16 | 1,113,003 | 2,404,868.06 |
| 1.41 | CAN AU | CANN GROUP LTD | BYP34X2 | 0.28 | 8,204,099 | 2,294,363.09 |
| 0.22 | CASH | 1.00 | 364,901 | 364,900.62 |
Investing involves risk, including the possible loss of principal. The investable universe of companies in which POTX may invest may be limited. The Fund invests in securities of companies engaged in Healthcare and Pharmaceutical sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. POTX is non-diversified.
POTX’s investments are concentrated in the cannabis industry, and the Fund may be susceptible to loss due to adverse occurrences affecting this industry. The cannabis industry is a very young, fast evolving industry with increased exposure to the risks associated with changes in applicable laws (including increased regulation, other rule changes, and related federal and state enforcement activities), as well as market developments, which may cause businesses to contract or close suddenly and negatively impact the value of securities held by the Fund. Cannabis Companies are subject to various laws and regulations that may differ at the state/local, federal and international level. These laws and regulations may significantly affect a Cannabis Company’s ability to secure financing and traditional banking services, impact the market for cannabis business sales and services, and set limitations on cannabis use, production, transportation, export and storage. The possession, use and importation of marijuana remains illegal under U.S. federal law. Federal law criminalizing the use of marijuana remains enforceable notwithstanding state laws that legalize its use for medicinal and recreational purposes. This conflict creates volatility and risk for all Cannabis Companies, and any stepped-up enforcement of marijuana laws by the federal government could adversely affect the value of the Fund’s investments. Given the uncertain nature of the regulation of the cannabis industry in the United States, the Fund’s investment in certain entities could, under unique circumstances, raise issues under one or more of those laws, and any investigation or prosecution related to those investments could result in expense and losses to the Fund.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning September 29, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to September 29, 2020, market price returns were based on the midpoint between the Bid and Ask price. Market price returns. NAVs are calculated using prices as of (4:00 PM Eastern Time). The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.
888-493-8631
Leave us a note